Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEL39: Melanoma Peptides and Tetanus Helper Peptide Vaccine in Melanoma
NCT00938223Phase 2Completed
- Start
- Aug 2000
- Primary completion
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 12-peptide melanoma vaccine in melanoma. Started Aug 2000; status: completed.
02
Drugs
12-peptide melanoma vaccine
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00938223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00938223.